Towards the development of improved thrombolytic agents.
作者信息
Lijnen H R, Collen D
机构信息
Center for Thrombosis and Vascular Research, K.U.L., Campus Gasthuisberg, Leuven, Belgium.
出版信息
Br J Haematol. 1991 Mar;77(3):261-6. doi: 10.1111/j.1365-2141.1991.tb08568.x.
Abstract
摘要
相似文献
1
Towards the development of improved thrombolytic agents.
Br J Haematol. 1991 Mar;77(3):261-6. doi: 10.1111/j.1365-2141.1991.tb08568.x.
2
Thrombolytic therapy.溶栓治疗。
Ann N Y Acad Sci. 1991;614:259-69. doi: 10.1111/j.1749-6632.1991.tb43708.x.
3
[Biochemical, pharmacologic and clinical properties of new thrombolytic agents].新型溶栓剂的生化、药理及临床特性
Internist (Berl). 1996 Jun;37(6):552-66.
4
Can plasminogen activators be improved?纤溶酶原激活剂可以得到改善吗？
Circulation. 1990 Nov;82(5):1874-6. doi: 10.1161/01.cir.82.5.1874.
5
Newer thrombolytic drugs for acute myocardial infarction.用于急性心肌梗死的新型溶栓药物。
Indian J Exp Biol. 1998 Jan;36(1):1-15.
6
[Thrombolytic therapy].[溶栓治疗]
Nihon Rinsho. 1998 Oct;56(10):2577-81.
7
[Thrombolytic therapy in acute myocardial infarct].[急性心肌梗死的溶栓治疗]
Med Klin (Munich). 1992 Feb 15;87(2):64-9.
8
[Fibrinolytic therapy in ischemic brain infarct].
Dtsch Med Wochenschr. 1987 Apr 10;112(15):603-8. doi: 10.1055/s-2008-1068107.
9
10
[Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
Wiad Lek. 1989 Apr 1;42(7):450-2.
Zotero 插件